000136923 001__ 136923
000136923 005__ 20240229105107.0
000136923 0247_ $$2doi$$a10.1016/j.jclinepi.2018.07.016
000136923 0247_ $$2pmid$$apmid:30076979
000136923 0247_ $$2ISSN$$a0895-4356
000136923 0247_ $$2ISSN$$a1878-5921
000136923 0247_ $$2altmetric$$aaltmetric:46065202
000136923 037__ $$aDKFZ-2018-01360
000136923 041__ $$aeng
000136923 082__ $$a610
000136923 1001_ $$0P:(DE-He78)f96b350b208db77bd493ed176dd66a83$$aQian, Jing$$b0$$eFirst author
000136923 245__ $$aBiomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
000136923 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2018
000136923 3367_ $$2DRIVER$$aarticle
000136923 3367_ $$2DataCite$$aOutput Types/Journal article
000136923 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1550750221_27365
000136923 3367_ $$2BibTeX$$aARTICLE
000136923 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000136923 3367_ $$00$$2EndNote$$aJournal Article
000136923 520__ $$aMost studies identifying inflammatory markers for early detection of colorectal cancer (CRC) were conducted using clinically manifest cases. We aimed to identify circulating inflammatory biomarkers for early detection of CRC and validate them in both a clinical setting and a true screening setting.A total of 92 inflammatory proteins were quantified in baseline plasma samples from individuals clinically diagnosed with CRC and neoplasm-free controls matched on age and sex (training set). A multi-marker panel was selected and evaluated in samples from another clinical setting (validation set C) and a screening setting (validation set S).In the training set (n=330) a 5-biomarker signature was selected that provided an AUC of 0.85 and 60.9% sensitivity to detect CRC at 90% specificity. When this algorithm was applied to validation set C (n=318), the AUC (0.80) and sensitivity (49.5%) at 90% specificity for CRC diagnosis were only slightly lower than those in the training set. In contrast, the diagnostic performance of the algorithm in validation set S (n=126) from a true screening setting was much poorer, with an AUC of 0.59 and a sensitivity of 28.6% at 90% specificity.An inflammation-related protein panel with apparently good diagnostic properties for CRC detection was identified and confirmed in an independent clinical validation set. However, the biomarker combination performed substantially worse in a validation sample from a true screening setting. Our results underline the importance of validation in screening settings subsequently to novel signature discovery for cancer early detection.
000136923 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000136923 588__ $$aDataset connected to CrossRef, PubMed,
000136923 7001_ $$0P:(DE-He78)eabbefb821cdb73961a5adf967330b62$$aTikk, Kaja$$b1
000136923 7001_ $$0P:(DE-He78)6c57e61dc44a62313e7075a0cefbb086$$aWerner, Simone$$b2$$udkfz
000136923 7001_ $$0P:(DE-HGF)0$$aBalavarca, Yesilda$$b3
000136923 7001_ $$0P:(DE-He78)609d3f1c1420bf59b2332eeab889cb74$$aSaadati, Maral$$b4$$udkfz
000136923 7001_ $$0P:(DE-He78)18a87b68d272401b45448c2af7bb1ea0$$aHechtner, Marlene$$b5$$udkfz
000136923 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b6$$eLast author
000136923 773__ $$0PERI:(DE-600)1500490-9$$a10.1016/j.jclinepi.2018.07.016$$gVol. 104, p. 24 - 34$$p24 - 34$$tJournal of clinical epidemiology$$v104$$x0895-4356$$y2018
000136923 909CO $$ooai:inrepo02.dkfz.de:136923$$pVDB
000136923 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f96b350b208db77bd493ed176dd66a83$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000136923 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)eabbefb821cdb73961a5adf967330b62$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000136923 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c57e61dc44a62313e7075a0cefbb086$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000136923 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000136923 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)609d3f1c1420bf59b2332eeab889cb74$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000136923 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)18a87b68d272401b45448c2af7bb1ea0$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000136923 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000136923 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000136923 9141_ $$y2018
000136923 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000136923 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN EPIDEMIOL : 2015
000136923 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000136923 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000136923 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000136923 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000136923 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000136923 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000136923 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000136923 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000136923 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000136923 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000136923 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000136923 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000136923 9201_ $$0I:(DE-He78)G110-20160331$$kG110$$lPräventive Onkologie$$x1
000136923 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x2
000136923 9201_ $$0I:(DE-He78)L501-20160331$$kL501$$lDKTK Frankfurt$$x3
000136923 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x4
000136923 980__ $$ajournal
000136923 980__ $$aVDB
000136923 980__ $$aI:(DE-He78)C070-20160331
000136923 980__ $$aI:(DE-He78)G110-20160331
000136923 980__ $$aI:(DE-He78)C060-20160331
000136923 980__ $$aI:(DE-He78)L501-20160331
000136923 980__ $$aI:(DE-He78)L101-20160331
000136923 980__ $$aUNRESTRICTED